{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T11:42:02Z","timestamp":1792582922539,"version":"4.5.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["CHEN21F0, 10. CF008614G224"],"award-info":[{"award-number":["CHEN21F0, 10. CF008614G224"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-77992-1","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:05:44Z","timestamp":1789826744000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dosing and delivery of bacteriophage therapy in a murine wound infection model"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5318-6851","authenticated-orcid":false,"given":"Yung-Hao","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5305-9968","authenticated-orcid":false,"given":"Tejas","family":"Dharmaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingquan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6963-9780","authenticated-orcid":false,"given":"Arne","family":"Echterhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Manasherob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy J.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7225-4925","authenticated-orcid":false,"given":"Cas","family":"de Leeuw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4330-5133","authenticated-orcid":false,"given":"Nana A.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4227-6163","authenticated-orcid":false,"given":"Tony H. W.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney","family":"Stannard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Hajfathalian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviv","family":"Hargil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1129-3382","authenticated-orcid":false,"given":"Hunter A.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6939-2909","authenticated-orcid":false,"given":"Julie","family":"Pourtois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7642-2081","authenticated-orcid":false,"given":"Maya","family":"Abhyankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis G.","family":"Blankenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6203-5853","authenticated-orcid":false,"given":"Derek","family":"Amanatullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9287-3401","authenticated-orcid":false,"given":"Ovijit","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2499-9448","authenticated-orcid":false,"given":"Paul L.","family":"Bollyky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,19]]},"reference":[{"key":"77992_CR1","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/j.1524-475X.2009.00543.x","volume":"17","author":"CK Sen","year":"2009","unstructured":"Sen, C. K. et al. Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen. 17, 763\u2013771 (2009).","journal-title":"Wound Repair Regen."},{"key":"77992_CR2","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1128\/JCM.00501-08","volume":"46","author":"K Kirketerp-M\u00f8ller","year":"2008","unstructured":"Kirketerp-M\u00f8ller, K. et al. Distribution, organization, and ecology of bacteria in chronic wounds. J. Clin. Microbiol. 46, 2717\u20132722 (2008).","journal-title":"J. Clin. Microbiol."},{"key":"77992_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2180-8-43","volume":"8","author":"SE Dowd","year":"2008","unstructured":"Dowd, S. E. et al. Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC Microbiol 8, 43 (2008).","journal-title":"BMC Microbiol"},{"key":"77992_CR4","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1099\/mic.0.028712-0","volume":"155","author":"S Malic","year":"2009","unstructured":"Malic, S. et al. Detection and identification of specific bacteria in wound biofilms using peptide nucleic acid fluorescent in situ hybridization (PNA FISH). Microbiology 155, 2603\u20132611 (2009).","journal-title":"Microbiology"},{"key":"77992_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1524-475X.2007.00321.x","volume":"16","author":"GA James","year":"2008","unstructured":"James, G. A. et al. Biofilms in chronic wounds. Wound Repair Regen. 16, 37\u201344 (2008).","journal-title":"Wound Repair Regen."},{"key":"77992_CR6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/wrr.12994","volume":"30","author":"E Eriksson","year":"2022","unstructured":"Eriksson, E. et al. Chronic wounds: treatment consensus. Wound Repair Regen. 30, 156\u2013171 (2022).","journal-title":"Wound Repair Regen."},{"key":"77992_CR7","doi-asserted-by":"publisher","first-page":"110929","DOI":"10.1016\/j.celrep.2022.110929","volume":"39","author":"N Kapel","year":"2022","unstructured":"Kapel, N., Caballero, J. D. & MacLean, R. C. Localized pmrB hypermutation drives the evolution of colistin heteroresistance. Cell Rep. 39, 110929 (2022).","journal-title":"Cell Rep."},{"key":"77992_CR8","doi-asserted-by":"crossref","unstructured":"Olalekan, A. et al. High incidence of carbapenemase-producing Pseudomonas aeruginosa clinical isolates from Lagos, Nigeria. JAC-Antimicrob. Resist. 5, (2023).","DOI":"10.1093\/jacamr\/dlad038"},{"key":"77992_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jgar.2019.10.016","volume":"21","author":"DO Ogbolu","year":"2020","unstructured":"Ogbolu, D. O., Piddock, L. J. V. & Webber, M. A. Opening Pandora\u2019s box: high-level resistance to antibiotics of last resort in Gram-negative bacteria from Nigeria. J. Glob. Antimicrob. Resist. 21, 211\u2013217 (2020).","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"77992_CR10","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/S0140-6736(05)79255-2","volume":"352","author":"N Woodford","year":"1998","unstructured":"Woodford, N., Palepou, M.-F. I., Babini, G., Bates, J. & Livermore, D. Carbapenemase-producing Pseudomonas aeruginosa in UK. Lancet 352, 546\u2013547 (1998).","journal-title":"Lancet"},{"key":"77992_CR11","doi-asserted-by":"publisher","first-page":"951","DOI":"10.12669\/pjms.305.5400","volume":"30","author":"F Khan","year":"2014","unstructured":"Khan, F., Khan, A. & Kazmi, S. U. Prevalence and susceptibility pattern of multi drug resistant clinical isolates of Pseudomonas aeruginosa in Karachi. Pak. J. Med. Sci. 30, 951\u2013954 (2014).","journal-title":"Pak. J. Med. Sci."},{"key":"77992_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4103\/0974-777X.192962","volume":"8","author":"JS Gill","year":"2016","unstructured":"Gill, J. S., Arora, S., Khanna, S. P. & Kumar, K. H. Prevalence of multidrug-resistant, extensively drug-resistant, and pandrug-resistant Pseudomonas aeruginosa from a tertiary level intensive care unit. J. Glob. Infect. Dis. 8, 155\u2013159 (2016).","journal-title":"J. Glob. Infect. Dis."},{"key":"77992_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.21608\/jesj.2022.143610.1020","volume":"27","author":"M Mohamed","year":"2022","unstructured":"Mohamed, M., Mohamed, H. & Afifi, M. Prevalence of MDR Pseudomonas aeruginosa in intensive care units and burned patients. J. Environ. Stud. 27, 10\u201315 (2022).","journal-title":"J. Environ. Stud."},{"key":"77992_CR14","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.2147\/IDR.S359157","volume":"15","author":"X Liu","year":"2022","unstructured":"Liu, X. et al. Risk factors for multidrug-resistant organisms infection in diabetic foot ulcer. Infect. Drug Resist. 15, 1627\u20131635 (2022).","journal-title":"Infect. Drug Resist."},{"key":"77992_CR15","unstructured":"Impact Initiatives and Research Coordination (IRC). WHO Bacterial Priority Pathogens List, 2024: Bacterial Pathogens of Public Health Importance to Guide Research, Development and Strategies to Prevent and Control Antimicrobial Resistance. (IRC, 2024)."},{"key":"77992_CR16","doi-asserted-by":"publisher","unstructured":"Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2019. (CDC, 2019) https:\/\/doi.org\/10.15620\/cdc:82532.","DOI":"10.15620\/cdc:82532"},{"key":"77992_CR17","doi-asserted-by":"crossref","unstructured":"Reig, S., Le Gouellec, A. & Bleves, S. What is new in the anti\u2013Pseudomonas aeruginosa clinical development pipeline since the 2017 WHO alert? Front. Cell. Infect. Microbiol. 12, 909731 (2022).","DOI":"10.3389\/fcimb.2022.909731"},{"key":"77992_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-44987-7","volume":"13","author":"AW Fiedler","year":"2023","unstructured":"Fiedler, A. W. et al. Phage therapy minimally affects the water microbiota in an Atlantic salmon (Salmo salar) rearing system while still preventing infection. Sci. Rep. 13, 19145 (2023).","journal-title":"Sci. Rep."},{"key":"77992_CR19","doi-asserted-by":"publisher","first-page":"e1294","DOI":"10.1093\/milmed\/usad385","volume":"189","author":"CJ Kovacs","year":"2024","unstructured":"Kovacs, C. J. et al. Disruption of biofilm by bacteriophages in clinically relevant settings. Mil. Med. 189, e1294\u2013e1302 (2024).","journal-title":"Mil. Med."},{"key":"77992_CR20","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1586\/eri.11.90","volume":"9","author":"B Burrowes","year":"2011","unstructured":"Burrowes, B., Harper, D. R., Anderson, J., McConville, M. & Enright, M. C. Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens. Expert Rev. Anti Infect. Ther. 9, 775\u2013785 (2011).","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"77992_CR21","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1164\/rccm.201904-0839LE","volume":"200","author":"S Maddocks","year":"2019","unstructured":"Maddocks, S. et al. Bacteriophage therapy of ventilator-associated pneumonia and empyema caused by Pseudomonas aeruginosa. Am. J. Respir. Crit. Care Med. 200, 1179\u20131181 (2019).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"77992_CR22","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1093\/cid\/ciaa705","volume":"73","author":"EJ Cano","year":"2021","unstructured":"Cano, E. J. et al. Phage therapy for limb-threatening prosthetic knee Klebsiella pneumoniae infection: Case report and in vitro characterization of anti-biofilm activity. Clin. Infect. Dis. 73, e144\u2013e151 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"77992_CR23","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/emph\/eoy005","volume":"2018","author":"BK Chan","year":"2018","unstructured":"Chan, B. K. et al. Phage treatment of an aortic graft infected with Pseudomonas aeruginosa. Evol. Med. Public Health 2018, 60\u201366 (2018).","journal-title":"Evol. Med. Public Health"},{"key":"77992_CR24","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.3390\/v15051210","volume":"15","author":"K Racenis","year":"2023","unstructured":"Racenis, K. et al. Successful bacteriophage-antibiotic combination therapy against multidrug-resistant Pseudomonas aeruginosa left ventricular assist device driveline infection. Viruses 15, 1210 (2023).","journal-title":"Viruses"},{"key":"77992_CR25","doi-asserted-by":"publisher","first-page":"ofad051","DOI":"10.1093\/ofid\/ofad051","volume":"10","author":"N Cesta","year":"2023","unstructured":"Cesta, N. et al. Application of phage therapy in a case of a chronic hip-prosthetic joint infection due to Pseudomonas aeruginosa: An Italian real-life experience and in vitro analysis. Open Forum Infect. Dis. 10, ofad051 (2023).","journal-title":"Open Forum Infect. Dis."},{"key":"77992_CR26","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1038\/s41591-025-03678-8","volume":"31","author":"BK Chan","year":"2025","unstructured":"Chan, B. K. et al. Personalized inhaled bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis. Nat. Med. 31, 1494\u20131501 (2025).","journal-title":"Nat. Med."},{"key":"77992_CR27","doi-asserted-by":"publisher","first-page":"569159","DOI":"10.3389\/fmed.2021.569159","volume":"8","author":"T Ferry","year":"2021","unstructured":"Ferry, T. et al. Case report: arthroscopic \u201cdebridement antibiotics and implant retention\u201d with local injection of personalized phage therapy to salvage a relapsing Pseudomonas aeruginosa prosthetic knee infection. Front. Med. 8, 569159 (2021).","journal-title":"Front. Med."},{"key":"77992_CR28","doi-asserted-by":"publisher","first-page":"S395","DOI":"10.1093\/cid\/ciad516","volume":"77","author":"R Mi\u0119dzybrodzki","year":"2023","unstructured":"Mi\u0119dzybrodzki, R. et al. Pharmacokinetic and pharmacodynamic obstacles for phage therapy from the perspective of clinical practice. Clin. Infect. Dis. 77, S395\u2013S400 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"77992_CR29","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1002\/med.21572","volume":"39","author":"K D\u0105browska","year":"2019","unstructured":"D\u0105browska, K. Phage therapy: what factors shape phage pharmacokinetics and bioavailability? Systematic and critical review. Med. Res. Rev. 39, 2000\u20132025 (2019).","journal-title":"Med. Res. Rev."},{"key":"77992_CR30","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02071-21","volume":"66","author":"GA Suh","year":"2022","unstructured":"Suh, G. A. et al. Considerations for the use of phage therapy in clinical practice. Antimicrob. Agents Chemother. 66, e0207121 (2022).","journal-title":"Antimicrob. Agents Chemother."},{"key":"77992_CR31","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/s41564-024-01705-x","volume":"9","author":"J-P Pirnay","year":"2024","unstructured":"Pirnay, J.-P. et al. Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study. Nat. Microbiol. 9, 1434\u20131453 (2024).","journal-title":"Nat. Microbiol."},{"key":"77992_CR32","doi-asserted-by":"crossref","unstructured":"Morozova, V. V., Kozlova, Y. N., Ganichev, D. A. & Tikunova, N. V. Bacteriophage treatment of infected diabetic foot ulcers. in Bacteriophage Therapy (eds Azeredo, J. & Sillankorva, S.) vol. 1693 151\u2013158 (Springer, 2018).","DOI":"10.1007\/978-1-4939-7395-8_13"},{"key":"77992_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2024.11.018","volume":"6","author":"R Nir-Paz","year":"2025","unstructured":"Nir-Paz, R. et al. Randomized double-blind study on safety and tolerability of TP-102 phage cocktail in patients with infected and non-infected diabetic foot ulcers. Med\u00a06, 100565 (2025).","journal-title":"Med"},{"key":"77992_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1473-3099(18)30482-1","volume":"19","author":"P Jault","year":"2019","unstructured":"Jault, P. et al. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1\/2 trial. Lancet Infect. Dis. 19, 35\u201345 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"77992_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41578-021-00362-4","volume":"7","author":"PP Kalelkar","year":"2022","unstructured":"Kalelkar, P. P., Riddick, M. & Garc\u00eda, A. J. Biomaterial-based delivery of antimicrobial therapies for the treatment of bacterial infections. Nat. Rev. Mater. 7, 39\u201354 (2022).","journal-title":"Nat. Rev. Mater."},{"key":"77992_CR36","doi-asserted-by":"publisher","first-page":"114258","DOI":"10.1016\/j.ejpb.2024.114258","volume":"198","author":"H Bai","year":"2024","unstructured":"Bai, H. et al. Phage-based antibacterial hydrogels for bacterial targeting and ablation: Progress and perspective. Eur. J. Pharm. Biopharm. 198, 114258 (2024).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"77992_CR37","doi-asserted-by":"publisher","first-page":"100656","DOI":"10.1016\/j.xcrm.2022.100656","volume":"3","author":"MS Bach","year":"2022","unstructured":"Bach, M. S. et al. Filamentous bacteriophage delays healing of Pseudomonas-infected wounds. Cell Rep. Med. 3, 100656 (2022).","journal-title":"Cell Rep. Med."},{"key":"77992_CR38","doi-asserted-by":"crossref","unstructured":"De Vries, C. R. et al. A delayed inoculation model of chronic Pseudomonas aeruginosa wound infection. J. Vis. Exp. e60599 (2020).","DOI":"10.3791\/60599-v"},{"key":"77992_CR39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1089\/wound.2019.1039","volume":"9","author":"JM Sweere","year":"2020","unstructured":"Sweere, J. M. et al. The immune response to chronic Pseudomonas aeruginosa wound infection in immunocompetent mice. Adv. Wound Care 9, 35\u201347 (2020).","journal-title":"Adv. Wound Care"},{"key":"77992_CR40","first-page":"1575","volume":"71","author":"D Fink","year":"2011","unstructured":"Fink, D. et al. Pseudomonas aeruginosa potentiates the lethal effect of intestinal ischemia-reperfusion injury: the role of in vivo virulence activation. J. Trauma 71, 1575\u20131582 (2011).","journal-title":"J. Trauma"},{"key":"77992_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53994-9","volume":"15","author":"MK Kim","year":"2024","unstructured":"Kim, M. K. et al. A blueprint for broadly effective bacteriophage-antibiotic cocktails against bacterial infections. Nat. Commun. 15, 9987 (2024).","journal-title":"Nat. Commun."},{"key":"77992_CR42","doi-asserted-by":"publisher","first-page":"264","DOI":"10.2967\/jnmt.111.090951","volume":"39","author":"DC Vines","year":"2011","unstructured":"Vines, D. C., Green, D. E., Kudo, G. & Keller, H. Evaluation of mouse tail-vein injections both qualitatively and quantitatively on small-animal PET tail scans. J. Nucl. Med. Technol. 39, 264\u2013270 (2011).","journal-title":"J. Nucl. Med. Technol."},{"key":"77992_CR43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.4274\/tjps.galenos.2021.72547","volume":"19","author":"MO Ilomuanya","year":"2022","unstructured":"Ilomuanya, M. O. et al. Chitosan-based microparticle encapsulated Acinetobacter baumannii phage cocktail in hydrogel matrix for the management of multidrug resistant chronic wound infection. Turk. J. Pharm. Sci. 19, 187\u2013195 (2022).","journal-title":"Turk. J. Pharm. Sci."},{"key":"77992_CR44","doi-asserted-by":"publisher","first-page":"102145","DOI":"10.1016\/j.nano.2019.102145","volume":"24","author":"JAR Barros","year":"2020","unstructured":"Barros, J. A. R. et al. Encapsulated bacteriophages in alginate-nanohydroxyapatite hydrogel as a novel delivery system to prevent orthopedic implant-associated infections. Nanomed. Nanotechnol. Biol. Med. 24, 102145 (2020).","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"77992_CR45","doi-asserted-by":"publisher","first-page":"118779","DOI":"10.1016\/j.ijpharm.2019.118779","volume":"572","author":"P Kaur","year":"2019","unstructured":"Kaur, P., Gondil, V. S. & Chhibber, S. A novel wound dressing consisting of PVA-SA hybrid hydrogel membrane for topical delivery of bacteriophages and antibiotics. Int. J. Pharm. 572, 118779 (2019).","journal-title":"Int. J. Pharm."},{"key":"77992_CR46","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/jbm.a.36790","volume":"108","author":"JA Wroe","year":"2020","unstructured":"Wroe, J. A., Johnson, C. T. & Garc\u00eda, A. J. Bacteriophage delivering hydrogels reduce biofilm formation in vitro and infection in vivo. J. Biomed. Mater. Res. A 108, 39\u201349 (2020).","journal-title":"J. Biomed. Mater. Res. A"},{"key":"77992_CR47","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.actbio.2020.01.021","volume":"105","author":"S Basu","year":"2020","unstructured":"Basu, S., Pacelli, S. & Paul, A. Self-healing DNA-based injectable hydrogels with reversible covalent linkages for controlled drug delivery. Acta Biomater. 105, 159\u2013169 (2020).","journal-title":"Acta Biomater."},{"key":"77992_CR48","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1021\/acs.biomac.3c01117","volume":"25","author":"C-C Tsai","year":"2024","unstructured":"Tsai, C.-C. et al. Injectable, shear-thinning, self-healing, and self-cross-linkable benzaldehyde-conjugated chitosan hydrogels as a tissue adhesive. Biomacromolecules 25, 1084\u20131095 (2024).","journal-title":"Biomacromolecules"},{"key":"77992_CR49","doi-asserted-by":"publisher","first-page":"127371","DOI":"10.1016\/j.ijbiomac.2023.127371","volume":"253","author":"R Wang","year":"2023","unstructured":"Wang, R., Yeh, Y.-J., An, Y.-N. & Virly. Engineering pH-sensitive erodible chitosan hydrogel composite containing bacteriophage: An interplay between hydrogel and bacteriophage against Staphylococcus aureus. Int. J. Biol. Macromol. 253, 127371 (2023).","journal-title":"Int. J. Biol. Macromol."},{"key":"77992_CR50","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adh8313","volume":"9","author":"JG Roth","year":"2023","unstructured":"Roth, J. G. et al. Tunable hydrogel viscoelasticity modulates human neural maturation. Sci. Adv. 9, eadh8313 (2023).","journal-title":"Sci. Adv."},{"key":"77992_CR51","doi-asserted-by":"publisher","first-page":"2004705","DOI":"10.1002\/advs.202004705","volume":"8","author":"DR Hunt","year":"2021","unstructured":"Hunt, D. R. et al. Engineered matrices enable the culture of human patient-derived intestinal organoids. Adv. Sci. 8, 2004705 (2021).","journal-title":"Adv. Sci."},{"key":"77992_CR52","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/nrd1008","volume":"2","author":"D Davies","year":"2003","unstructured":"Davies, D. Understanding biofilm resistance to antibacterial agents. Nat. Rev. Drug Discov. 2, 114\u2013122 (2003).","journal-title":"Nat. Rev. Drug Discov."},{"key":"77992_CR53","doi-asserted-by":"publisher","first-page":"20","DOI":"10.12968\/jowc.2017.26.1.20","volume":"26","author":"M Malone","year":"2017","unstructured":"Malone, M. et al. The prevalence of biofilms in chronic wounds: a systematic review and meta-analysis of published data. J. Wound Care 26, 20\u201325 (2017).","journal-title":"J. Wound Care"},{"key":"77992_CR54","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/j.1574-6976.2011.00322.x","volume":"36","author":"EE Mann","year":"2012","unstructured":"Mann, E. E. & Wozniak, D. J. Pseudomonas biofilm matrix composition and niche biology. FEMS Microbiol. Rev. 36, 893\u2013916 (2012).","journal-title":"FEMS Microbiol. Rev."},{"key":"77992_CR55","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.284.5418.1318","volume":"284","author":"JW Costerton","year":"1999","unstructured":"Costerton, J. W., Stewart, P. S. & Greenberg, E. P. Bacterial biofilms: a common cause of persistent infections. Science 284, 1318\u20131322 (1999).","journal-title":"Science"},{"key":"77992_CR56","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nrmicro2960","volume":"11","author":"H Vlamakis","year":"2013","unstructured":"Vlamakis, H., Chai, Y., Beauregard, P., Losick, R. & Kolter, R. Sticking together: building a biofilm the Bacillus subtilis way. Nat. Rev. Microbiol. 11, 157\u2013168 (2013).","journal-title":"Nat. Rev. Microbiol."},{"key":"77992_CR57","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.micro.57.030502.090720","volume":"57","author":"MR Parsek","year":"2003","unstructured":"Parsek, M. R. & Singh, P. K. Bacterial biofilms: an emerging link to disease pathogenesis. Annu. Rev. Microbiol. 57, 677\u2013701 (2003).","journal-title":"Annu. Rev. Microbiol."},{"key":"77992_CR58","doi-asserted-by":"crossref","unstructured":"Uberoi, A., McCready-Vangi, A. & Grice, E. A. The wound microbiota: microbial mechanisms of impaired wound healing and infection. Nat. Rev. Microbiol. 22, 507\u2013521 (2024).","DOI":"10.1038\/s41579-024-01035-z"},{"key":"77992_CR59","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3390\/v15030803","volume":"15","author":"F Shafigh Kheljan","year":"2023","unstructured":"Shafigh Kheljan, F. et al. Design of phage-cocktail\u2013containing hydrogel for the treatment of Pseudomonas aeruginosa\u2013infected wounds. Viruses 15, 803 (2023).","journal-title":"Viruses"},{"key":"77992_CR60","doi-asserted-by":"publisher","first-page":"1032052","DOI":"10.3389\/fcimb.2022.1032052","volume":"12","author":"S Patpatia","year":"2022","unstructured":"Patpatia, S. et al. Rapid hydrogel-based phage susceptibility test for pathogenic bacteria. Front. Cell. Infect. Microbiol. 12, 1032052 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"77992_CR61","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3390\/antibiotics10020130","volume":"10","author":"HY Kim","year":"2021","unstructured":"Kim, H. Y., Chang, R. Y. K., Morales, S. & Chan, H.-K. Bacteriophage-delivering hydrogels: Current progress in combating antibiotic resistant bacterial infection. Antibiotics 10, 130 (2021).","journal-title":"Antibiotics"},{"key":"77992_CR62","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/s41551-018-0263-5","volume":"2","author":"R Agarwal","year":"2018","unstructured":"Agarwal, R. et al. Inhaled bacteriophage-loaded polymeric microparticles ameliorate acute lung infections. Nat. Biomed. Eng. 2, 841\u2013849 (2018).","journal-title":"Nat. Biomed. Eng."},{"key":"77992_CR63","doi-asserted-by":"publisher","first-page":"120850","DOI":"10.1016\/j.ijpharm.2021.120850","volume":"605","author":"RYK Chang","year":"2021","unstructured":"Chang, R. Y. K., Okamoto, Y., Morales, S., Kutter, E. & Chan, H.-K. Hydrogel formulations containing non-ionic polymers for topical delivery of bacteriophages. Int. J. Pharm. 605, 120850 (2021).","journal-title":"Int. J. Pharm."},{"key":"77992_CR64","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jconrel.2021.01.024","volume":"331","author":"H-Y Shen","year":"2021","unstructured":"Shen, H.-Y. et al. Controlled-release of free bacteriophage nanoparticles from 3D-plotted hydrogel fibrous structure as potential antibacterial wound dressing. J. Control. Release 331, 154\u2013163 (2021).","journal-title":"J. Control. Release"},{"key":"77992_CR65","doi-asserted-by":"publisher","first-page":"7201","DOI":"10.1021\/cm503974g","volume":"26","author":"JE Bean","year":"2014","unstructured":"Bean, J. E. et al. Triggered release of bacteriophage K from agarose\/hyaluronan hydrogel matrixes by Staphylococcus aureus virulence factors. Chem. Mater. 26, 7201\u20137208 (2014).","journal-title":"Chem. Mater."},{"key":"77992_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-38318-4","volume":"9","author":"E Rubalskii","year":"2019","unstructured":"Rubalskii, E. et al. Fibrin glue as a local drug-delivery system for bacteriophage PA5. Sci. Rep. 9, 2091 (2019).","journal-title":"Sci. Rep."},{"key":"77992_CR67","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adh4327","volume":"9","author":"H Ren","year":"2023","unstructured":"Ren, H. et al. Injectable, self-healing hydrogel adhesives with firm tissue adhesion and on-demand biodegradation for sutureless wound closure. Sci. Adv. 9, eadh4327 (2023).","journal-title":"Sci. Adv."},{"key":"77992_CR68","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1021\/acs.biomac.9b00020","volume":"20","author":"PK Sharma","year":"2019","unstructured":"Sharma, P. K. & Singh, Y. Glyoxylic hydrazone linkage-based PEG hydrogels for covalent entrapment and controlled delivery of doxorubicin. Biomacromolecules 20, 2174\u20132184 (2019).","journal-title":"Biomacromolecules"},{"key":"77992_CR69","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1021\/acsmacrolett.9b00020","volume":"8","author":"Y Hua","year":"2019","unstructured":"Hua, Y. et al. Adaptable to mechanically stable hydrogels based on the dynamic covalent cross-linking of thiol-aldehyde addition. ACS Macro Lett. 8, 310\u2013314 (2019).","journal-title":"ACS Macro Lett."},{"key":"77992_CR70","doi-asserted-by":"crossref","unstructured":"Liu, D. et al. The safety and toxicity of phage therapy: a review of animal and clinical studies. Viruses 13, 1268 (2021).","DOI":"10.3390\/v13071268"},{"key":"77992_CR71","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s12223-021-00946-1","volume":"67","author":"A Zyman","year":"2022","unstructured":"Zyman, A., G\u00f3rski, A. & Mi\u0119dzybrodzki, R. Phage therapy of wound-associated infections. Folia Microbiol. 67, 193\u2013201 (2022).","journal-title":"Folia Microbiol."},{"key":"77992_CR72","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3390\/ph16101347","volume":"16","author":"KM Chung","year":"2023","unstructured":"Chung, K. M., Nang, S. C. & Tang, S. S. The safety of bacteriophages in treatment of diseases caused by multidrug-resistant bacteria. Pharmaceuticals 16, 1347 (2023).","journal-title":"Pharmaceuticals"},{"key":"77992_CR73","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/cid\/ciy947","volume":"69","author":"L El Haddad","year":"2019","unstructured":"El Haddad, L., Harb, C. P., Gebara, M. A., Stibich, M. A. & Chemaly, R. F. A systematic and critical review of bacteriophage therapy against multidrug-resistant ESKAPE organisms in humans. Clin. Infect. Dis. 69, 167\u2013178 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"77992_CR74","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.micpath.2016.08.001","volume":"99","author":"P Chadha","year":"2016","unstructured":"Chadha, P., Katare, O. P. & Chhibber, S. In vivo efficacy of single phage versus phage cocktail in resolving burn wound infection in BALB\/c mice. Microb. Pathog. 99, 68\u201377 (2016).","journal-title":"Microb. Pathog."},{"key":"77992_CR75","doi-asserted-by":"crossref","unstructured":"Hernandez, A., Patil, N. K. & Bohannon, J. K. A murine model of full-thickness scald burn injury with subsequent wound and systemic bacterial infection. in Sepsis (ed. Walker, W. E.) vol. 2321 111\u2013120 (Springer, 2021).","DOI":"10.1007\/978-1-0716-1488-4_10"},{"key":"77992_CR76","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/wrr.12016","volume":"21","author":"H Tr\u00f8strup","year":"2013","unstructured":"Tr\u00f8strup, H. et al. Pseudomonas aeruginosa biofilm aggravates skin inflammatory response in BALB\/c mice in a novel chronic wound model. Wound Repair Regen. 21, 292\u2013299 (2013).","journal-title":"Wound Repair Regen."},{"key":"77992_CR77","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1524-475X.2012.00793.x","volume":"20","author":"G Zhao","year":"2012","unstructured":"Zhao, G. et al. Time course study of delayed wound healing in a biofilm-challenged diabetic mouse model. Wound Repair Regen. 20, 342\u2013352 (2012).","journal-title":"Wound Repair Regen."},{"key":"77992_CR78","doi-asserted-by":"publisher","first-page":"e00140","DOI":"10.1128\/mBio.00140-17","volume":"8","author":"D Pletzer","year":"2017","unstructured":"Pletzer, D., Mansour, S. C., Wuerth, K., Rahanjam, N. & Hancock, R. E. W. New mouse model for chronic infections by Gram-negative bacteria enabling the study of anti-infective efficacy and host-microbe interactions. mBio 8, e00140\u201317 (2017).","journal-title":"mBio"},{"key":"77992_CR79","doi-asserted-by":"publisher","DOI":"10.1093\/pnasnexus\/pgad406","volume":"2","author":"T Dharmaraj","year":"2023","unstructured":"Dharmaraj, T. et al. Rapid assessment of changes in phage bioactivity using dynamic light scattering. PNAS Nexus 2, pgad406 (2023).","journal-title":"PNAS Nexus"},{"key":"77992_CR80","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01506-25","volume":"70","author":"A Echterhof","year":"2026","unstructured":"Echterhof, A. et al. Whole-body distribution of three Pseudomonas phages characterized by a translational physiologically based pharmacokinetic model. Antimicrob. Agents Chemother. 70, e01506-25 (2026).","journal-title":"Antimicrob. Agents Chemother."},{"key":"77992_CR81","doi-asserted-by":"publisher","DOI":"10.1126\/science.aat9691","volume":"363","author":"JM Sweere","year":"2019","unstructured":"Sweere, J. M. et al. Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection. Science 363, eaat9691 (2019).","journal-title":"Science"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77992-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77992-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77992-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T11:01:51Z","timestamp":1792580511000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77992-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,19]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["77992"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-77992-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,19]]},"assertion":[{"value":"25 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"10984"}}